Lv22
130 积分 2026-01-12 加入
Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial
7小时前
求助中
Abstract CT001: Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): Phase 3 KEYNOTE-689 study
7小时前
求助中
Clinical study of Carrilizumab combined with concurrent radiotherapy and chemotherapy in the treatment of locally advanced head and neck squamous cell carcinoma: prospective, randomized, controlled study
7小时前
求助中
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
8小时前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
8小时前
已关闭
Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): phase 3 KEYNOTE-689 study
8小时前
已关闭
Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): a randomized, controlled, open label, phase II clinical trial
8小时前
已关闭
皖公网安备34019202002308
